Flurina Suter was born and grew up in Zurich, Switzerland, where she conducted her Bachelor of Science in Biology at the University of Zurich from 2016 to 2020. She continued her studies at the Epidemiology, Biostatistics and Prevention Institute (EBPI) at the University of Zurich. In 2022, she attained her Master of Science in Biostatistics and subsequently joined the EBPI as a research assistant under the supervision of Prof. Dr. Sabine Rohrmann. Flurina Suter worked on several research projects in the field of chronic disease epidemiology, mainly focusing on the influence of lifestyle factors on cancer risk and mortality. From March to September 2023, she additionally worked part-time as a scientific collaborator at the Research Centre of the NICER Foundation in Zurich, Switzerland, and at the National Agency for Cancer Registration of the NICER Foundation, Zurich, Switzerland. As scientific collaborator, she mainly worked on two projects, examining the subsite-specific colon cancer trends in Switzerland and updating the cancer prevalence statistics in Switzerland using the completeness index method. In September 2023, she started her PhD, funded by the Swiss Cancer Research, at the EBPI under the main supervision of Prof. Dr. Sabine Rohrmann. In her PhD project Flurina Suter investigates the manifold effects of the COVID-19 pandemic and the pandemic measures on several cancer outcomes, such as cancer diagnoses, cancer stage distribution, and cancer survival. For her project, she works with population-based data provided by the cantonal cancer registry of the Swiss cantons of Zurich, Zug, Schaffhausen and Schwyz which is led by her PhD supervisor, Prof. Dr. Sabine Rohrmann. With her research, Flurina Suter aims to provide a detailed insight into the effects of the COVID-19 pandemic on cancer outcomes in Switzerland and to shape decisions of the government and public health authorities during a future pandemic.